Bandingkan Harga & Kinerja Sinar Eka Selaras Tbk. (ERAL) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sinar Eka Selaras Tbk. dan Tempo Scan Pacific Tbk.: Sinar Eka Selaras Tbk. diperdagangkan di Rp300 (kapitalisasi pasar 1,55 T, volume 24 jam 2,08 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.780 (kapitalisasi pasar 12,58 T, volume 24 jam 216,9 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 8,1× kapitalisasi pasar Sinar Eka Selaras Tbk., dan Sinar Eka Selaras Tbk. lebih aktif diperdagangkan (2,08 jt vs 216,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ERAL | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 1,55 T | 12,58 T |
Volume | 2,08 jt | 216,9 rb |
Lot | 20,8 rb | 2,17 rb |
Perputaran | 626,62 jt | 599 jt |
Harga Rata-rata | 301,33 | 2.761,65 |
Nilai Transaksi | 626,62 jt | 599 jt |
Harga Ekuilibrium Indikatif | — | 2.790 |
Volume Ekuilibrium Indikatif | — | 3,9 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sinar Eka Selaras Tbk.
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Selengkapnya di halaman ERAL →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
